Virulence of Streptococci

Details Virulence of Streptococci Virulence of Streptococci

2009-12-03

2011-12-06

Graser, Jennifer (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S185100, C424S190100, C435S975000

Reexamination Certificate

active

08071111

ABSTRACT:
The invention relates to the field of diagnosis of and vaccination against Streptococcal infections and to the detection of virulence markers of Streptococci. The invention discloses a method for modulating virulence of aStreptococcus, the method comprising modifying a genomic fragment ofStreptococcuswherein the genomic fragment comprises at least a functional part of a fragment identifiable by hybridization inStreptococcus suisto a nucleic acid or fragment thereof as shown in FIG.5.

REFERENCES:
patent: 5610011 (1997-03-01), Smith et al.
patent: 5681570 (1997-10-01), Yang et al.
patent: 5733765 (1998-03-01), Mollet et al.
patent: 5786184 (1998-07-01), Mollet et al.
patent: 5928900 (1999-07-01), Masure et al.
patent: 5948900 (1999-09-01), Yother et al.
patent: 5981229 (1999-11-01), Masure et al.
patent: 6699703 (2004-03-01), Doucette-Stamm et al.
patent: 7109006 (2006-09-01), Smith
patent: 7125548 (2006-10-01), Smith
patent: 2002/0055168 (2002-05-01), Smith
patent: 2007/0053938 (2007-03-01), Smith
patent: 0 750 043 (2001-05-01), None
patent: WO 92/16630 (1992-10-01), None
patent: WO 95/06732 (1995-03-01), None
patent: WO 95/31548 (1995-11-01), None
patent: WO 96/21465 (1996-07-01), None
patent: WO 98/19689 (1998-05-01), None
patent: 00/06738 (2000-02-01), None
patent: WO 00/05378 (2000-02-01), None
patent: WO 02/38597 (2002-05-01), None
patent: WO 02/061070 (2002-08-01), None
Murphy et al. Pediatr. Infect. Dis. J. 1989. 8: S66-S68.
Yamanaka et al (J. Pediatrics. 1993. 122(2): 212-218).
Fraser et al (Science. 1998. 281: 375-388).
Nelson et al (Nature. 1999. 399: 323-329).
1997/1998 Stratagene catalog (p. 118, 1997/1998).
Allgaier et al., Relatedness ofStreptococcus suisisolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits. Journal of Clinical Microbiology, 2001, pp. 445-453, vol. 39, No. 2.
Busque et al., Immunization of pigs againstStreptococcus suisserotype 2 infection using a live avirulent strain, Can J Vet Res., Oct. 1997, pp. 275-279, vol. 61, No. 4.
Charland et al.,Streptococcus suisserotype 2 mutants deficient in capsular expression, Microbiology, Feb. 1998, pp. 325-332, vol. 144, No. 2.
Chothia et al., The Embo Journal, 1986, pp. 823-826, vol. 5, No. 4.
Christie et al., Expression of fibronectin-binding protein FbpA modulates adhesion inStreptococcus gordonii, Microbiology, 2002, pp. 1615-1625, vol. 148.
Courtney et al., Cloning, Sequencing, and Expression of a Fibronectin/Fibrinogen-Binding Protein from Group AStreptococci, Infection and Immunity, Sep. 1994, pp. 3937-3946, vol. 62, No. 9.
Database EMBL ‘Online’ McNab,S. gordoniipartial aldB gene, cshA gene & fbpA gene, Database accession No. X65164, XP002213089, 2002.
De Greeff et al., Contribution of Fibronectin-Binding Protein to Pathogenesis ofStreptococcus suisSerotype 2, Infection and Immunity, Mar. 2002, pp. 1319-1325, vol. 70, No. 3.
De Greeff et al., Distribution of Environmentally Regulated Genes ofStreptococcus suisSerotype 2 amongS. suisSerotypes and Other Organisms, Journal of Clinical Microbiology, Sep. 2002, pp. 3261-3268, vol. 40, No. 9.
Dutch Text Annual Report ID-DLOStreptococcus Suis, 1996, with English translation of said report.
Elliott et al., Streptococcal infection in young pigs. V. An immunogenic polysaccharide fromStreptoccoccus suistype 2 with particular reference to vaccination against streptococcal meningitis in pigs, Oct. 1980, pp. 275-285, vol. 85, No. 2.
Kawabata et al., Molecular cloning, sequence and characterization of a novel streptococcal phosphoglycerate dehydrogenase gene, Oral Microbiology and Immunology, 2000, pp. 58-62, vol. 15.
Joh et al., Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells, Matrix Biology, 1999, pp. 211-223, vol. 18.
Kolkman et al., Diversity of capsular polysaccharide synthesis gene clusters inStreptococcus pneumoniae, J. Biochem., May 1998, pp. 937-945, vol. 123, No. 5.
Koskiniemi et al., Identification of two genes, cpsX and cpxY, with putative regulatory function on capsule expression in group B streptococci, FEMS Immunology and Medical Microbiology, 1998, pp. 159-168, vol. 21.
McNab, Cloning and sequence analysis of thymidine kinase from the oral bacteriumStreptococcus gordonii, FEMS Microbiology Letters, 1996, pp. 103-110, vol. 135.
Munoz et al., Characterization of IS1515, a Functional Insertion Sequence inStreptococcus pneumoniae, Journal of Bacteriology, Mar. 1998, pp. 1381-1388, vol. 180, No. 6.
PCT International Preliminary Examination Report, PCT/NL01/00805, dated Sep. 8, 2002, 2 pages.
PCT International Search Report, PCT/NL01/00805, dated Jun. 6, 2002, 3 pages.
Quessy et al., Immunization of mice againstStreptococcus suisserotype 2 infections using a live avirulent strain, Can J. Vet Res., Oct. 1994, pp. 299-301, vol. 58, No. 4.
Roberts et al., The biochemistry and genetics of capsular polysaccharide production in bacteria, Ann. Rev. Microbiol., 1996, pp. 285-315, vol. 50.
Segers et al., Characterisation of the gene encoding suilysin fromStreptococcus suisand expression in field strains, FEMS Microbiology Letters, 1998, pp. 255-261, vol. 167.
Smith et al., Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) ofStreptococcus suistype 2, Infection and Immunity, 1992, pp. 2361-2367, vol. 60, No. 6.
Smith et al., Environmentally regulated genes ofStreptococcus suis: identification by the use of iron-restricted conditions in vitro and by experimental infections of piglets, Microbiology, 2001. pp. 271-280, vol. 147.
Smith et al., High efficiency transformation and gene inactivation inStreptococcus suistype 2, Microbiology, Jan. 1995, pp. 181-188, vol. 141.
Smith et al., Identification and characterization of the cps locus ofStreptococcus suisserotype 2: the capsule protects against phagocytosis and is an important virulence factor, Infect Immun., Apr. 1999, pp. 1750-1756, vol. 67, No. 4.
Smith et al., Mutants ofStreptococcus suisTypes 1 and 2 Impaired in Expression of Muramidase-Released Protein and Extracellular Protein Induce Disease in Newborn Germfree Pigs, Infection and Immunity, Oct. 1996, pp. 4409-4412, vol. 64, No. 10.
Smith et al., Repeats in an extracellular protein of weakly pathogenic strains ofStreptococcus suistype 2 are absent in pathogenic strains, Infection and Immunity, 1993, pp. 3318-3326, vol. 61, No. 8.
Smith et al., Selection of virulence-associated determinants ofStreptococcus suisserotype 2 by in vivo complementation, Infection and Immunity, Mar. 2001, pp. 1961-1966, vol. 69, No. 3.
Smith et al., The cps locus ofStreptococcus suisserotype 2: genetic determinant for the synthesis of sialic acid, Microbial Pathogenesis, 2000, pp. 127-134, vol. 29, No. 2.
Watson et al., Pneumococcal Virulence Factors and Host Immune Responses to Them. European Journal of Clinical Microbiology & Infectious Diseases, Jun. 1995, pp. 479-490, vol. 14, No. 6.
Office Action for U.S. Appl. No. 10/632,117, dated Jun. 10, 2004.
Office Action for U.S. Appl. No. 10/632,117, dated Nov. 3, 2004.
Office Action for U.S. Appl. No. 10/632,117, dated Jul. 26, 2005.
Office Action for U.S. Appl. No. 10/632,117, dated Oct. 3, 2007.
Office Action for U.S. Appl. No. 10/632,117, dated Jun. 20, 2008.
Office Action for U.S. Appl. No. 10/632,117, dated Dec. 23, 2008.
Office Action for U.S. Appl. No. 10/632,117, dated Jun. 16, 2009.
Office Action for U.S. Appl. No. 11/516,691, dated Feb. 26, 2008.
Office Action for U.S. Appl. No. 11/516,691, dated Apr. 22, 2008.
Office Action for U.S. Appl. No. 11/516,691, dated Dec. 5, 2008.
Office Action for U.S. Appl. No. 11/516,691, dated Jun. 22, 2009.
Office Action for U.S. Appl. No. 11/516,691, dated Nov. 25, 2009.
Database EMBL [Online]Streptococcus pneumoniaeadherence and virulence protein A (pavA) gene, complete cds, Nov. 4, 1999, XP002332859, retrieved from EBI accession No. EM—PRO:AF181976, Database accession No. AF181976.
Database EMBL [Online],S.gordoniipartial aldB gene, cshA gene & fbpA gene, XP0023328

Affiliated with

Also associated with

Rating

Virulence of Streptococci does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Virulence of Streptococci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virulence of Streptococci will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4309394